[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100260222":3},{"organization":4,"outcomesModule":7,"designInfo":13,"detailedDescription":11,"studyPopulation":16,"armGroups":17,"interventions":23,"overallOfficials":11,"centralContacts":31,"locations":38,"responsibleParty":83,"collaborators":11,"id":85,"slug":86,"hasResults":87,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":91,"eligibilityCriteria":92,"healthyVolunteers":87,"sex":93,"minAge":94,"maxAge":11,"enrollmentInfo":95,"targetDuration":98,"studyType":99,"phases":11,"briefSummary":100,"conditions":101,"keywords":11,"overallStatus":41,"whyStopped":11,"lastUpdateSubmitDate":103,"lastUpdatePostDateStruct":104,"startDateStruct":107,"completionDateStruct":109,"leadSponsor":111,"locationsCount":112},{"fullName":5,"class":6},"Gustave Roussy, Cancer Campus, Grand Paris","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":11,"otherOutcomes":11},[9],{"measure":10,"description":11,"timeFrame":12},"Study of genetic factors who might lead to secondary iatrogenic pathology due to treatment of a childhood cancer",null,"From enrollment to the end of study at 15 years",{"allocation":11,"interventionModel":11,"interventionModelDescription":11,"primaryPurpose":11,"observationalModel":14,"timePerspective":15,"maskingInfo":11},"COHORT","PROSPECTIVE","Patients treated for a paediatric malignancies before the year 2000 having survived two years after treatment of solid tumor diagnosed before 18 years old",[18],{"label":19,"type":11,"description":11,"interventionNames":20},"Patients treated for cancer in childhood",[21,22],"Procedure: saliva samples","Procedure: blood samples",[24,28],{"type":25,"name":26,"description":11,"armGroupLabels":27,"otherNames":11},"PROCEDURE","saliva samples",[19],{"type":25,"name":29,"description":11,"armGroupLabels":30,"otherNames":11},"blood samples",[19],[32],{"name":33,"role":34,"phone":35,"phoneExt":36,"email":37},"Brice Fresneau, MD","CONTACT","0142114622","+33","brice.fresneau@gustaveroussy.fr",[39,55,69],{"facility":40,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Gustave Roussy Cancer Campus Grand Paris","RECRUITING","Villejuif","Val de Marne","94805","France","FR",{"type":48,"coordinates":49},"Point",[50,51],2.35992,48.7939,{"lat":51,"lon":50},[54],{"name":33,"role":34,"phone":35,"phoneExt":36,"email":37},{"facility":56,"status":41,"city":57,"state":11,"zip":58,"country":45,"countryCode":46,"cosmosGeoPoint":59,"geoPoint":63,"contacts":64},"Centre Léon Bérard","Lyon","69008",{"type":48,"coordinates":60},[61,62],4.84789,45.74906,{"lat":62,"lon":61},[65],{"name":66,"role":34,"phone":67,"phoneExt":11,"email":68},"Amandine Bertrand, MD","0469166685","amandine.bertrand@lyon.unicancer.fr",{"facility":70,"status":41,"city":71,"state":11,"zip":72,"country":45,"countryCode":46,"cosmosGeoPoint":73,"geoPoint":77,"contacts":78},"Institut Curie","Paris","75005",{"type":48,"coordinates":74},[75,76],2.3488,48.85341,{"lat":76,"lon":75},[79],{"name":80,"role":34,"phone":81,"phoneExt":11,"email":82},"François Doz, MD","0144324550","francois.doz@curie.fr",{"type":84,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100260222","iatrogenic-effects-of-treatment-for-childhood-cancer-constitution-of-a-biological-samples-bank-100260222",false,"NCT02666625","Iatrogenic Effects of Treatment for Childhood Cancer Constitution of a Biological Samples Bank","Study of Iatrogenic Effects of Treatment for Childhood Cancer - Constitution of a Biological Samples Bank as Part of a Cohort of Patients (Cohort FCCSS)","BIO-F","Inclusion Criteria:\n\n* Patients treated for a first cancer in childhood\n* Adult patients\n* Signed informed consent\n* Patient insured or enjoying a social security scheme\n\nExclusion Criteria:\n\n* Minor patients\n* Under legal protection measure patients\n* Refusal of consent","ALL","18 Years",{"count":96,"type":97},10000,"ESTIMATED","15 Years","OBSERVATIONAL","The constitution of a biological samples bank, attached to epidemiological studies Cohort F-CCSS on iatrogenic effects of treatment of childhood cancer, will identify genetic variants that can modulate the iatrogenic risks of these treatments. The main objective is to provide a biological samples bank to consider, besides the carcinogenic risks, the risk of other iatrogenic diseases in these children, in particular cardiac, cerebrovascular, lung, bone and kidney. These conditions can be very incapacitating and in some cases, fatal. Their impact, however, is poorly estimated as occurring in adulthood, they are rarely made in relation to the treatment received in childhood. The overall project is expected to eventually better define the iatrogenic effects prevention strategies for cancer treatment.",[102],"Paediatric Malignancies","2026-09-04",{"date":105,"type":106},"2026-09-10","ACTUAL",{"date":108,"type":106},"2013-07-23",{"date":110,"type":97},"2036-12",{"name":5,"class":6},3]